VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $253,100 | -59.8% | 10,000 | -69.4% | 0.00% | -50.0% |
| Q3 2022 | $630,000 | -16.3% | 32,683 | +10.6% | 0.00% | 0.0% |
| Q2 2022 | $753,000 | +20.1% | 29,550 | +21.3% | 0.00% | +100.0% |
| Q1 2022 | $627,000 | -58.4% | 24,361 | -29.0% | 0.00% | -50.0% |
| Q4 2021 | $1,506,000 | +264.6% | 34,301 | +261.3% | 0.00% | +100.0% |
| Q3 2021 | $413,000 | -18.1% | 9,493 | -11.0% | 0.00% | 0.0% |
| Q2 2021 | $504,000 | +35.8% | 10,670 | +47.6% | 0.00% | 0.0% |
| Q1 2021 | $371,000 | -30.5% | 7,228 | -63.8% | 0.00% | 0.0% |
| Q4 2020 | $534,000 | – | 19,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |